Public Calendar: February 13-19, 2022

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Janet Woodcock, M.D., Acting Commissioner

Event Date: 02/16/2022
Location: Virtual
Subject: Trial Updates and Protocols
FDA Participant/Group: PETER STEIN;
Non FDA Participant/Group: Parties involved in Accelerating COVID-19 Therapeutic Interventions and Vaccines

Event Date: 02/18/2022
Location: Virtual
Subject: Selection Committee Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of the Patient-Centered Outcomes Research Institute

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 02/15/2022
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members from the National Association of State Departments of Agriculture

Event Date: 02/16/2022
Location: Arlington, VA
Subject: National Association of State Departments of Agriculture Winter Policy Conference; FDA Food Safety Update
FDA Participant/Group: N/A
Non FDA Participant/Group: U.S. State commissioners, secretaries and directors of agriculture, federal agencies, congressional leaders, and industry stakeholders

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Jacqueline O'Shaughnessy, Acting Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 02/14/2022
Location: Virtual
Subject: MITRE's Sentinel PDUFA VI Assessment Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Patricia Carter, Stuart Williams (MITRE);

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 02/14/2022
Location: Virtual
Subject: Silicon Valley Bank Leerink Global Healthcare Conference; Keynote Address
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the Silicon Valley Bank Leerink Global Healthcare Conference

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 02/14/2022
Location: Virtual
Subject: SARS-CoV-2 Serology Testing
FDA Participant/Group: TIMOTHY STENZEL;
Non FDA Participant/Group: Michael Prevoznik and James Davis (Quest); Meg Sullivan (Office of the Secretary); Thomas Inglesby (Executive Office of the President); Bruce Tromberg (National Institute of Biomedical Imaging and Bioengineering);

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event